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Several investigators have shown that pulsatile perfusionimproves vital-organ recovery after hypothermic car-diopulmonary bypass (CPB) with or without deephypothermic circulatory arrest (DHCA).1-4 Nevertheless,
pulsatile perfusion remains controversial, and only a few pediatric
centers use it routinely.5 The main reason for this controversy is
lack of quantification of pulsatile and nonpulsatile pressure-flow
waveforms. We propose to end the controversy by quantifying pul-
satile flow with Shepard’s energy equivalent pressure (EEP) for-
mula, which accounts for both arterial-pressure and pump-flow
waveforms and not pressure waveforms alone.6-8 Generation of
pulsatile flow depends on an energy gradient rather than on a pres-
sure gradient. The following formula is used to define the EEP:
EEP = (∫fpdt)/(∫fdt)
where f is the pump flow rate (in milliliters per second), p is the arte-
rial pressure, and the time integrals are over one pulse cycle. The
EEP, which is expressed in millimeters of mercury, is the ratio of the
areas beneath the hemodynamic power curve (∫fpdt) and the pump
flow-rate curve (∫fdt) at the end of the flow and pressure cycles.
To determine whether the pulsatile or nonpulsatile perfusion
mode yields the greatest hemodynamic energy during CPB, we
evaluated 6 pediatric pumps in terms of the EEP before and after
DHCA in a neonatal piglet model.
Experimental Design
Thirty-nine piglets (average weight, 3 kg) were subjected to CPB
with one of the following: a hydraulically driven physiologic pul-
satile pump (n = 7; Medical Engineering Consultants, Bishop,
Calif), a Jostra HL-20 pulsatile roller pump (n = 6; Jostra USA,
Austin, Tex), a Stöckert SIII pulsatile roller pump (n = 6; Stöckert,
Munich, Germany), a Stöckert SIII mast-mounted pulsatile roller
pump with a miniature roller head (n = 7), a Stöckert SIII mast-
mounted nonpulsatile roller pump with a miniature roller head (n
= 6), or a Stöckert CAPS nonpulsatile roller pump (n = 7). All ani-
mals received humane care, as described in the “Guide for the Care
and Use of Laboratory Animals” of the National Research Council
(National Academy Press, revised 1996).
Each piglet was premedicated with intramuscular ketamine
hydrochloride (20 mg/kg) and acepromazine maleate (1 mg/kg).
Once an intravenous line was established, a 3-mm endotracheal
tube was inserted for mechanical ventilation. Intravenous boluses
of fentanyl citrate (100 µg/kg) and pancuronium bromide (0.3
mg/kg) were then given. After a median sternotomy was per-
formed, the ascending aorta and the right atrium were cannulated
with a 10F aortic cannula (DLP, Inc, Grand Rapids, Mich) and a
21F single-stage venous cannula (Polystan A/S, Varlose,
Denmark), respectively.
The extracorporeal circuit was primed with heparinized fresh
blood and lactated Ringer’s solution. The priming volume for the
whole circuit was approximately 600 mL. During CPB, the hema-
tocrit level was maintained at 20%. In all the experiments, a hol-
low-fiber membrane oxygenator (Capiox SX10; Terumo Corp,
Tokyo, Japan) and a pediatric arterial filter (Terumo Corp) were
used. During pulsatile CPB, the pump rate was maintained at 150
beats/min, and the stroke volume was maintained at 1 mL/kg.
Pump flow was maintained at 150 mL · kg–1 · min–1 in all the
groups. An ultrasonic flow probe (T109; Transonic Systems, Inc,
Ithaca, NY) was placed in the circuit beyond the membrane oxy-
genator to measure blood flow. During CPB, the mean arterial
pressure (MAP) was maintained at approximately 45 mm Hg by
adding isoflurane through the oxygenator gas-inflow conduit. At
the end of the experiment, the animal was killed with an intra-
venous bolus of pentobarbital sodium and phenytoin sodium
(Beuthanasia-D; 0.22 mg/kg).
Once CPB was begun, each animal underwent 15 minutes of
normothermic CPB, 25 minutes of hypothermia, 60 minutes of
deep hypothermic circulatory arrest, 10 minutes of cold reperfu-
sion, and 40 minutes of rewarming. After the ascending aorta was
crossclamped at 18°C, a 40-mL dose of crystalloid cardioplegic
(modified Kirklin) solution was manually administered into the
aorta. During cooling and rewarming, alpha-stat acid-base man-
agement was used. In all experiments phenoxybenzamine (1
mg/kg), a potent vasodilator and α-adrenergic blocker, was used 5
minutes before the initiation of CPB.
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Waveforms of the femoral artery pressure (MAP), precannula
extracorporeal circuit pressure (ECCP), and pump flow were col-
lected during 3 experimental stages: (1) normothermic CPB (after
15 minutes on pump at 36°C); (2) deep hypothermic CPB (imme-
diately before DHCA at 18°C); and (3) the postrewarming period
(after 60 minutes of DHCA, 10 minutes of cold reperfusion, and 40
minutes of rewarming).
Analysis of variance with repeated measures was used for sta-
tistical analysis among the 6 groups. All results were expressed as
means ± standard deviation.
Results
Tables 1 and 2 summarize the results. The physiologic pulsatile
pump produced the greatest hemodynamic energy. Compared with
all the other pumps except the physiologic pulsatile model, the
Jostra and SIII pulsatile roller pumps produced a significantly
higher average increase in hemodynamic energy (from MAP to
EEP and from ECCP to EEP). This extra energy produced by pul-
satile pumps may maintain capillary patency and increase the flow
of lymph fluid in the tissues by generating oscillatory movements
at the cellular level.9 During deep hypothermic CPB and after
rewarming, the results did not differ from those observed during
normothermic CPB. The SIII mast-mounted pulsatile roller pump
failed to generate higher hemodynamic energy than the nonpul-
satile pumps because it had a miniature roller head. None of the
nonpulsatile roller pumps produced extra energy. There were no
differences between the MAP-EEP or the ECCP-EEP during non-
pulsatile perfusion.
The physiologic pulsatile pump used in this study is hydrauli-
cally driven and is unique in that it has 2 pump chambers. The first
chamber is placed between the venous reservoir and the membrane
oxygenator, and the second chamber is positioned after the mem-
brane oxygenator. Therefore, in this set-up the oxygenator does not
affect the quality of the pulsatility. A detailed description of this
pump is presented elsewhere.10 All the other pumps used in this
study, except the physiologic pulsatile pump, are approved by the
Food and Drug Administration for clinical use. The Capiox hol-
low-fiber membrane oxygenator and the DLP aortic cannula were
chosen specifically for this study because of their previous excel-
lent performance with pulsatile flow pumps.11,12
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TABLE 1. Femoral artery pressure: percentage of change from MAP to EEP
Pump Normothermic CPB (mm Hg) Hypothermic CPB (mm Hg) Postrewarming period (mm Hg)
Physiologic pulsatile 12.9 ± 3.2 (50.4 ± 4.9 to 56.9 ± 5.2)†‡ 15.3 ± 4.0 (45.8 ± 8 to 52.6 ± 8.8)†‡ 16.3 ± 4.5 (48.4 ± 18.3 to 56.2 ± 20.8)†‡
Jostra HL-20 pulsatile roller 5.3 ± 1.2 (39.6 ± 6.9 to 41.6 ± 6.8)* 4.8 ± 0.8 (44.7 ± 6.4 to 46.8 ± 6.3)* 6.2 ± 1.8 (39 ± 3.4 to 41.5 ± 3.6)*
Stöckert SIII pulsatile roller 3.7 ± 1.2 (43.5 ± 10.7 to 45 ± 10.8)* 4.5 ± 0.5 (38.2 ± 6.7 to 39.9 ± 6.8)* 4.2 ± 1.2 (49.2 ± 11.8 to 51.1 ± 12.4)*
Stöckert SIII mast-mounted –0.3 ± 1.6 (45.2 ± 8.7 to 45.2 ± 9.1)*†‡ –0.2 ± 1.4 (43.9 ± 7.4 to 43.7 ± 7.1)*†‡ –1.8 ± 1.7 (51.6 ± 12.4 to 50.5 ± 11.5)*†‡
pulsatile roller
Stöckert SIII mast-mounted –0.2 ± 1.8 (43 ± 4.8 to 43 ± 5.0)*†‡ –0.4 ± 0.7 (46.1 ± 3.6 to 45.9 ± 3.6)*†‡ –0.9 ± 2.2 (51.9 ± 9.2 to 51.4 ± 9.1)*†‡
nonpulsatile roller
Stöckert CAPS 0.7 ± 0.5 (49 ± 5.4 to 49.4 ± 5.3)*†‡ 0.9 ± 0.9 (43.9 ± 12.1 to 44.2 ± 12.0)*†‡ 0.7 ± 0.5 (47.4 ± 14 to 47.8 ± 14.1)*†‡
nonpulsatile roller
Values are given as means ± standard deviation.
*P < .0001 versus the Physiologic pulsatile pump.
†P < .001 versus the Jostra HL-20 pulsatile roller pump.
‡P < .01 versus the Stöckert SIII pulsatile roller pump.
TABLE 2. Preaortic cannula ECCP: Percentage of change from ECCP to EEP
Pump Normothermic CPB (mm Hg) Hypothermic CPB (mm Hg) Postrewarming period (mm Hg)
Physiologic pulsatile 45.9 ± 13.1 (70.4 ± 6.9 to 102.6 ± 12.4)†‡ 46.4 ± 11.3 (65.6 ± 13.7 to 95.7 ± 19.3)†‡ 52.0 ± 10.0 (74.5 ± 17.3 to 112.1 ± 21.0)†‡
Jostra HL-20 pulsatile 14.5 ± 3.9 (59.5 ± 11.9 to 67.9 ± 12.5)* 12.2 ± 2.6 (66.6 ± 6.9 to 74.6 ± 6.6)* 14.8 ± 2.7 (63.1 ± 9.4 to 72.6 ± 11.8)*
roller
Stöckert SIII pulsatile 9.2 ± 1.3 (64.1 ± 19.2 to 69.9 ± 20.4)* 11.2 ± 1.8 (54.9 ± 7.8 to 61.0 ± 8.5)* 9.0 ± 2.8 (70.1 ± 15.5 to 76.1 ± 15.5)*
roller
Stöckert SIII 1.2 ± 3.0 (65.8 ± 14.1 to 66.6 ± 14.6)*†‡ 2.6 ± 2.2 (68.4 ± 19.1 to 69.9 ± 18.4)*†‡ –0.5 ± 1.4 (69.9 ± 19 to 69.5 ± 18.5)*†‡
mast-mounted
pulsatile roller
Stöckert SIII 1.3 ± 1.8 (59.1 ± 5.7 to 59.9 ± 6.6)*†‡ 1 ± 0.2 (70.5 ± 6.6 to 71.2 ± 6.6)*†‡ –0.7 ± 1.3 (73.4 ± 13.6 to 72.9 ± 13.7)*†‡
mast-mounted
nonpulsatile roller
Stöckert CAPS 1.9 ± 0.4 (68.2 ± 13.8 to 69.5 ± 13.8)*†‡ 1.7 ± 0.8 (59.4 ± 8.7 to 60.3 ± 8.5)*†‡ 1.9 ± 0.7 (73.9 ± 10.1 to 75.2 ± 10.1)*†‡
nonpulsatile roller
Values are given as means ± standard deviation.
*P < .0001 versus the Physiologic pulsatile pump.
†P < .001 versus the Jostra HL-20 pulsatile roller pump.
‡P < .01 versus the Stöckert SIII pulsatile roller pump.
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Conclusion
Most of the pediatric pulsatile pumps (hydraulically driven or pul-
satile roller) that we tested, but not all of them, generated signifi-
cantly higher hemodynamic energy than did the conventional, non-
pulsatile pumps. On the basis of these results, further studies are
warranted to confirm that the extra energy produced by pulsatile
flow improves vital-organ function after CPB. For direct compari-
son of the different perfusion modes, the EEP formula must be used
to quantify pulsatile and nonpulsatile pressure-flow waveforms.
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